Structure

(-)-Scopolamine

CAS
138-12-5
Catalog Number
ACM138125
Category
Other Products
Molecular Weight
303.35
Molecular Formula
C17H21NO4

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
HYOSCINE;Azatricyclo [3.3.1.02,4] non-7-yl ester;Benzeneaceticacid,α-(hydroxymethyl)-,(1α,2β,4β,5α,7β)-9-methyl-3-oxa-9-;(1alpha,2beta,4beta,5alpha,7beta)-alpha-(Hydroxymethyl)-benzeneacetic acid 9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl ester
What is the molecular formula of scopolamine?

The molecular formula of scopolamine is C17H21NO4.

What is the molecular weight of scopolamine?

The molecular weight of scopolamine is 303.35 g/mol.

What are some synonyms for scopolamine?

Some synonyms for scopolamine are hyoscine, (-)-Hyoscine, 51-34-3, Scopine, and (-)-tropate.

What is the IUPAC Name of scopolamine?

The IUPAC Name of scopolamine is [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0 2,4 ]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate.

How was scopolamine first synthesized?

Scopolamine was first synthesized in 1959.

What are some therapeutic applications of scopolamine?

Scopolamine is approved for the prevention of nausea and vomiting associated with motion sickness and surgical procedures.

What are some adverse effects of scopolamine?

Scopolamine can induce adverse effects related to alteration of the parasympathetic nervous system and cholinergic signalling.

When was scopolamine first approved by the FDA?

Scopolamine was first approved by the FDA on December 31, 1979.

What is the InChIKey of scopolamine?

The InChIKey of scopolamine is STECJAGHUSJQJN-USLFZFAMSA-N.

How is scopolamine functionally related to tropic acid?

Scopolamine is functionally related to (S)-tropic acid.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Shopping basket
qrcodex
Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.